Skip to main content

Abstract

A high percentage of cytologic specimens obtained from pulmonary nodules, masses, and cystic lesions are malignant. Indeed the majority of cytologic studies of material obtained from the lower respiratory tract are performed for the investigation as to whether or not a pulmonary lesion is malignant. The lungs are the site of a large number of primary and metastatic malignancies as well as a smaller number of benign neoplasms and localized nonneoplastic conditions. Cytologic recognition of an imaging finding as definitively malignant is extraordinarily important for development of a therapeutic plan. Given today’s therapeutic requirements, a number of specific questions must be answered including (1) whether a lesion is malignant or benign, (2) whether the lesion represents a primary carcinoma or some other lesion, (3) whether the carcinoma is small cell or non-small cell in type, and (4) whether a non-small cell carcinoma is an adenocarcinoma or a squamous cell carcinoma. A number of molecular and immunohistochemical studies are often required for the proper characterization of primary pulmonary carcinomas. The malignancy risk for the malignant category is approximately 90%.

Positive for malignancy aspirates represent a group of neoplasms that unequivocally display malignant cytologic features including those of squamous cell carcinomas, adenocarcinoma, small cell carcinomas, large cell neuroendocrine carcinoma, lymphoma, and a variety of metastatic malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Johnston WW, Frable WJ. The cytopathology of the respiratory tract. A review. Am J Pathol. 1976;84:372–424.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Suprun H, Pedio G, Ruttner JR. The diagnostic reliability of cytologic typing in primary lung cancer with a review of the literature. Acta Cytol. 1980;24:494–500.

    CAS  PubMed  Google Scholar 

  3. Pilotti S, Rilke F, Gribaudi G, Damascelli B. Fine needle aspiration biopsy cytology of primary and metastatic pulmonary tumors. Acta Cytol. 1982;26:661–6.

    CAS  PubMed  Google Scholar 

  4. Ebrahimi M, Auger M, Jung S, Fraser RS. Diagnostic concordance of non-small cell lung carcinoma subtypes between biopsy and cytology specimens obtained during the same procedure. Cancer ctopathology. 2016;124:737–43.

    Article  PubMed  Google Scholar 

  5. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137:668–84.

    Article  PubMed  Google Scholar 

  6. Rekhtman N, Brandt SM, Sigel CS, et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol. 2011;6:451–8.

    Article  PubMed  Google Scholar 

  7. Feller-Kopman D, Yung RC, Burroughs F, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer. 2009;117:482–90.

    PubMed  Google Scholar 

  8. Witt BL, Cohen MB, Chadwick BE, Stephenson PD, Abasolo P, Schmidt RL. Cytomorphology is often insufficient to categorize non-small-cell lung carcinoma on FNA specimens. Diagn Cytopathol. 2016 Feb;44(2):73–9.

    Article  PubMed  Google Scholar 

  9. Yilmaz A, Uskül TB, Bayramgürler B, Baran R. Cell type accuracy of transthoracic fine needle aspiration material in primary lung cancer. Respirology. 2001;6(2):91–4.

    Article  CAS  PubMed  Google Scholar 

  10. Yildiz-Aktas IZ, Sturgis CD, Barkan GA, Souers RJ, Fraig MM, Laucirica R, Khalbuss WE, Moriarty AT. Primary pulmonary non-small cell carcinomas: the College of American Pathologists Interlaboratory Comparison Program confirms a significant trend toward subcategorization based upon fine-needle aspiration cytomorphology alone. Arch Pathol Lab Med. 2014 Jan;138(1):65–70.

    Article  PubMed  Google Scholar 

  11. Casiraghi M, De Pas T, Maisonneuve P, Brambilla D, Ciprandi B, Galetta D, Borri A, Gasparri R, Petrella F, Tessitore A, Guarize J, Donghi SM, Veronesi G, Solli P, Spaggiari L. A 10-year single-center experience on 708 lung metastasectomies: the evidence of the “international registry of lung metastases”. J Thorac Oncol. 2011 Aug;6(8):1373–8.

    Article  PubMed  Google Scholar 

  12. Pastorino U, McCormack PM, Ginsberg RJ. A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases. Chest Surg Clin N Am. 1998 Feb;8(1):197–202.

    CAS  PubMed  Google Scholar 

  13. Sigel CS, Rudomina DE, Sima CS, et al. Predicting pulmonary adenocarcinoma outcome based on a cytology grading system. Cancer Cytopathol. 2012;120:35–43.

    Article  PubMed  Google Scholar 

  14. Layfield LJ, Dodd L, Witt B. Malignancy risk for the categories: non-diagnostic, benign, atypical, suspicious, and malignant used in the categorization of endobronchial ultrasound guided-fine needle aspirates of pulmonary nodules. Diagn Cytopathol. 2015;43(11):892–6.

    Article  PubMed  Google Scholar 

  15. Saad RS, Silverman JF. Respiratory cytology: differential diagnosis and pitfalls. Diagn Cytopathol. 2010;38(4):297–307.

    PubMed  Google Scholar 

  16. Funai K, Yokose T, Ishii G, Araki K, Yoshida J, Nishimura M, Nagai K, Nishiwaki Y, Ochiai A. Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol. 2003;27(7):978–84.

    Article  PubMed  Google Scholar 

  17. Rodriguez EF, Monaco SE, Dacic S. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification. Cancer Cytopathol. 2013;121(11):629–37.

    Article  PubMed  Google Scholar 

  18. Nandeesh BN, Crasta J, Tirumalae R. Fine-needle aspiration cytology in the diagnosis and typing of lung carcinomas. Clin Cancer Investig J. 2015;4(5):637–44.

    Article  CAS  Google Scholar 

  19. MacDonald LL, Yazdi HM. Fine-needle aspiration biopsy of bronchioloalveolar carcinoma. Cancer. 2001;93(1):29–34.

    Article  CAS  PubMed  Google Scholar 

  20. Auger M, Katz RL, Johnston DA. Differentiating cytological features of bronchioloalveolar carcinoma from adenocarcinoma of the lung in fine-needle aspirations: a statistical analysis of 27 cases. Diagn Cytopathol. 1997 Mar;16(3):253–7.

    Article  CAS  PubMed  Google Scholar 

  21. Geisinger KR, Travis WD, Perkins LA, Zakowski MF. Aspiration cytomorphology of fetal adenocarcinoma of the lung. Am J Clin Pathol. 2010 Dec;134(6):894–902.

    Article  PubMed  Google Scholar 

  22. Morency E, Rodriguez Urrego PA, Szporn AH, Beth Beasley M, Chen H. The “drunken honeycomb” feature of pulmonary mucinous adenocarcinoma: a diagnostic pitfall of bronchial brushing cytology. Diagn Cytopathol. 2013;41(1):63–6.

    Article  PubMed  Google Scholar 

  23. Chhieng DC. Fine-needle aspiration cytology of pulmonary mucinous cystadenocarcinoma. Diag Cytopathol. 2008;36(8):581–5.

    Article  Google Scholar 

  24. Jayaram G, Yaccob R, Liam CK. Mucinous carcinoma (colloid carcinoma) of the lung diagnosed by fine needle aspiration cytology: a case report. Malays J Pathol. 2003 Jun;25(1):63–8.

    PubMed  Google Scholar 

  25. Tsuta K, Shibuki Y, Maezawa N, Tochigi N, Maeshima AM, Sasajima Y, Asamura H, Matsuno Y. Cytological features of signet-ring cell carcinoma of the lung: comparison with the goblet-cell-type adenocarcinoma of the lung. Diagn Cytopathol. 2009;37(3):159–63.

    Article  PubMed  Google Scholar 

  26. Gaffey MJ, Mills SE, Ritter JH. Clear cell tumors of the lower respiratory tract. Semin Diagn Pathol. 1997;14(4):222–32.

    CAS  PubMed  Google Scholar 

  27. Shelton DA, Rana DN, Holbrook M, Taylor P, Bailey S. Adenosquamous carcinoma of the lung diagnosed by cytology?: a diagnostic dilemma. Diagn Cytopathol. 2012;40(9):830–3.

    Article  PubMed  Google Scholar 

  28. Okada S, Kudo M, Hirano T, Ishikawa A, Ebihara Y. Sarcomatoid anaplastic carcinoma of the lung with osteoclast-like giant cell reaction: a case report with special references to cytological findings. J Jpn Soc Clin Cytol. 1999;38:170–6.

    Article  Google Scholar 

  29. Jordan AG, Predmore L, Sullivan MM, Memoli VA. The cytodiagnosis of well-differentiated neuroendocrine carcinoma. A distinct clinicopathologic entity. Acta Cytol. 1987;31(4):464–70.

    CAS  PubMed  Google Scholar 

  30. Gephardt GN, Belovich DM. Cytology of pulmonary carcinoid tumors. Acta Cytol. 1982;26(4):434–8.

    CAS  PubMed  Google Scholar 

  31. Nguyen GK. Cytopathology of pulmonary carcinoid tumors in sputum and bronchial brushings. Acta Cytol. 1995;39(6):1152–60.

    CAS  PubMed  Google Scholar 

  32. Renshaw AA, Haja J, Lozano RL, Wilbur DC, Cytology Committee, College of American Pathologists. Distinguishing carcinoid tumor from small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists non-gynecologic cytology program. Arch Pathol Lab Med. 2005;129(5):614–8.

    PubMed  Google Scholar 

  33. Renshaw AA, Voytek TM, Haja J, Wilbur DC, Cytology Committee, College of American Pathologists. Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists non-gynecologic cytology program. Arch Pathol Lab Med. 2005;129(5):619–23.

    PubMed  Google Scholar 

  34. Walker WP, Wittchow RJ, Bottles K, Layfield LJ, Hirschowitz S, Cohen MB. Paranuclear blue inclusions in small cell undifferentiated carcinoma: a diagnostically useful finding demonstrated in fine-needle aspiration biopsy smears. Diagn Cytopathol. 1994;10(3):212–5.

    Article  CAS  PubMed  Google Scholar 

  35. Jimenez-Heffernan JA, Lopez-Ferrer P, Vicandi B, Mariño A, Tejerina E, Nistal M, Viguer JM. Fine-needle aspiration cytology of large cell neuroendocrine carcinoma of the lung: a cytohistologic correlation study of 11 cases. Cancer. 2008;114(3):180–6.

    Article  PubMed  Google Scholar 

  36. Wiatrowska BA, Krol J, Zakowski MF. Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis. Diagn Cytopathol. 2001 Jan;24(1):58–64.

    Article  CAS  PubMed  Google Scholar 

  37. Kakinuma H, Mikami T, Iwabuchi K, Yokoyama M, Hattori M, Ohno E, Kuramoto H, Jiang SX, Okayasu I. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. Cancer. 2003 Aug 25;99(4):247–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lester J. Layfield .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Layfield, L.J., Rossi, E.D., Moreira, A.L., Baloch, Z. (2019). Category VI: Malignant. In: Layfield, L., Baloch, Z. (eds) The Papanicolaou Society of Cytopathology System for Reporting Respiratory Cytology. Springer, Cham. https://doi.org/10.1007/978-3-319-97235-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97235-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-97234-3

  • Online ISBN: 978-3-319-97235-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics